* Download comes with a free subscription to our newsletter. You can unsubscribe any time. You will not get duplicate emails if you download more than one report.
Anticholinergic drugs that have been prescribed for depression, bladder conditions, and Parkinson’s in over 27 million patients have been linked to a significant increase in dementia in a dose-dependent manner (higher the dose, the higher the risk).
This study was not a randomized controlled trial which, of course, means causation cannot be established. However, the anticholinergic drugs were prescribed for a wide-range of conditions including depression, bladder conditions, and Parkinson’s disease. Additionally, the link to dementia was dose-dependent meaning those taking higher doses had a higher dementia risk. Both of these points strengthen the data and suggest that physicians and patients should consider the potential risk of long-term cognitive effects that these drugs may have.